Graves’ ophthalmopathy – thyroid eye disease
Graves’ disease (GD) is an autoimmune disorder that affects thyroid. It is caused by antibody, named thyroid-stimulating immunoglobulin (TIS) that acts like thyroid stimulating hormone (TSH), resulting in thyroid hormone overproduction – condition called hyperthyroidism. TSH receptors are located on...
Main Authors: | Dagna Siedlecka, Wojciech Micał, Ewa Krzewicka-Romaniuk, Rashed Mustafa Nazzal |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2019-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | http://www.ojs.ukw.edu.pl/index.php/johs/article/view/7271 |
Similar Items
-
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
by: Suzuki N, et al.
Published: (2018-04-01) -
A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
by: Soma Farag, et al.
Published: (2021-05-01) -
Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves’ disease
by: Laura Carolina Delfino, et al.
Published: (2017-02-01) -
Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
by: Laura Penta, et al.
Published: (2019-01-01) -
Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
by: Prabhu Roshan S, et al.
Published: (2012-06-01)